InspireMD Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,913.00
6,300.00
3,257.00
7,516.00
3,710.00
9,384
Total Accounts Receivable
2,127.00
994.00
547.00
513.00
850.00
820
Inventories
1,593.00
1,924.00
753.00
500.00
533.00
1,134
Other Current Assets
272.00
150.00
75.00
65.00
62.00
81
Total Current Assets
18,905.00
9,368.00
4,632.00
8,594.00
5,155.00
11,419
Net Property, Plant & Equipment
550.00
622.00
472.00
379.00
476.00
421
Intangible Assets
-
-
87.00
38.00
-
-
Other Assets
1,290.00
1,469.00
502.00
399.00
476.00
448
Total Assets
20,745.00
11,459.00
5,693.00
9,410.00
6,107.00
12,288
ST Debt & Current Portion LT Debt
-
3,809.00
4,149.00
2,680.00
-
Accounts Payable
831.00
909.00
512.00
618.00
328.00
Other Current Liabilities
3,212.00
3,755.00
2,173.00
1,480.00
2,154.00
Total Current Liabilities
4,043.00
8,473.00
6,834.00
4,778.00
2,482.00
Long-Term Debt
-
5,086.00
1,099.00
-
-
Provision for Risks & Charges
600.00
687.00
706.00
587.00
624.00
Total Liabilities
4,643.00
14,246.00
8,639.00
5,365.00
3,106.00
Common Equity (Total)
16,102.00
2,787.00
2,946.00
4,045.00
2,727.00
Total Shareholders' Equity
16,102.00
2,787.00
2,946.00
4,045.00
3,001.00
Total Equity
16,102.00
2,787.00
2,946.00
4,045.00
3,001.00
Liabilities & Shareholders' Equity
20,745.00
11,459.00
5,693.00
9,410.00
6,107.00
Preferred Stock (Carrying Value)
-
-
-
-
274.00

About InspireMD

View Profile
Address
4 Menorat Hamaor Street
Tel Aviv TA 67448
Israel
Employees -
Website http://www.inspiremd.com
Updated 07/08/2019
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.